Augusta University
Augusta, Georgia, 30912, United States
Location status: Recruiting
NCT Number: NCT06862050
The overall purpose of this pilot study is to assess the feasibility and acceptability of an in-person faith-based intervention to help people stop tobacco use. The study will address use of different types of tobacco products, such as smoking combustible cigarettes, cigarillos and little filtered cigars, and using/vaping electronic nicotine delivery systems (vape pens, e-cigs, and JUUL).
The intervention consists of 12 weekly meetings in which participants will go through BREATHE Free, a study guide curriculum designed to teach character strengths and promote resilience. This pilot research will provide information and practical lessons on how to improve Breathe Free implementation, increase engagement of the local people, and maximize their benefit.
The main questions it aims to answer are:
* Do participants find BREATHE Free curriculum acceptable, engaging and helpful to stop tobacco use? * Do participants who complete BREATHE Free curriculum smoke fewer cigarettes per day?
Researchers will assign participants to either BREATHE Free curriculum or usual care.
Participants will:
* Be taught BREATHE Free curriculum or be given information and referral to tobacco quit line * BREATHE Free group will attend 12 group meetings held on the university campus * All participants will answer interview questions related to tobacco use, character strengths and resilience * Expired Carbon Monoxide (CO) will be assessed in all participants.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Augusta, Georgia, 30912, United States
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Curriculum will teach practices: love, perspective, prudence, hope, humility, forgiveness, spirituality, self-control, teamworking, perseverance, gratitude, and joy.
Time frame: Weekly assessments, with first assessment in week 2 and last assessment in week 12.
Active participation in weekly session as reflected by number of weekly accomplishments
Time frame: Program evaluation will be administered on last meeting (week 12).
Program evaluation questionnaire will assess, on a 1-5 (ranging from completely disagree - completely agree) scale, participants' attitude and confidence to quit tobacco us.
Time frame: Program evaluation will be administered on last meeting (week 12).
Program evaluation questionnaire will assess, on a 1-10 (rated from 1=not at all helpful to 10=extremely helpful) scale, perceived helpfulness of BREATHE Free curriculum in helping participants stop tobacco use.
Time frame: Measured in baseline and weeks 12 and 16
Number of cigarettes (or cigars) smoked per day (CPD)
Time frame: Measured in baseline and weeks 12 and 16
Biochemically verified point prevalence abstinence (7 days)
Time frame: Measured in baseline and weeks 12 and 16
Connor-Davidson Resilience Scale 10 (CD-RISC-10) score
Contact information is provided by the study sponsor or research team.
Augusta University
Other
BREATHE Free: Character Strength and Resilience-Based Curriculum for Successful Tobacco Treatment: a Pilot Feasibility Trial
Acronym: BF
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06762210
Behavior, Chemically-Induced Disorders
Fayoum, Alexandria Governorate, Egypt
View Trial DetailsNCT06883097
Acquired Immunodeficiency Syndrome, Behavior
Winston-Salem, North Carolina, United States
View Trial DetailsNCT06901713
Behavior, Chemically-Induced Disorders
Hangzhou, China
View Trial DetailsNCT07030387
Behavior, Chemically-Induced Disorders
Efeler, Aydın, Turkey (Türkiye)
View Trial Details